<DOC>
	<DOCNO>NCT01717729</DOCNO>
	<brief_summary>To prospectively evaluate whether use combine radiofrequency ablation ( RFA ) percutaneous iodine-125 ( 125I ) seed implantation result well survival compare use RFA alone patient hepatocellular carcinoma .</brief_summary>
	<brief_title>Hepatocellular Carcinoma Treated With Iodine-125 Implantation</brief_title>
	<detailed_description>This study local ethical committee approve ; patient give write informed consent . A total 136 patient randomly assign undergo RFA-125I ( n = 68 ; 42 men , 26 woman ; mean age , 50.7 year ; age range , 29-73 year ) RFA alone ( n = 68 ; 47 men , 21 woman ; mean age , 48.9 year ; age range , 30-74 year ) . Patients viable tumor compute tomography ( CT ) 4 week treatment receive additional treatment . Rates local tumor progression overall survival evaluate use Kaplan-Meier log-rank test , respectively . The relative prognostic significance variable predict overall survival time tumor recurrence metastasis assess multivariate Cox proportional hazard regression logistic regression analysis , respectively .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Coal Tar</mesh_term>
	<mesh_term>Iodine</mesh_term>
	<mesh_term>Cadexomer iodine</mesh_term>
	<criteria>( ) age 1875 year refusal undergo surgery ; ( b ) solitary HCC 7.0 cm diameter small multiple ( three ) HCCs 3.0 cm diameter small ; ( c ) lesion visible ultrasonography ( US ) , acceptable safe path lesion skin see US scan ; ( ) extrahepatic metastasis ; ( e ) image evidence tumor invasion major portal hepatic vein branch ; ( f ) history encephalopathy , ascites refractory diuretic , variceal bleeding ; ( g ) platelet count 40 000 cells/mm3 ( h ) previous treatment HCC except liver resection . Exclusion criterion include active thyroid disease , serious concurrent medical illness , extrahepatic disease , previous anticancer treatment surgery , histologically prove nonHCC tumor woman pregnant breastfeeding .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>HCC , RFA , Iodine-125 , Recurrence</keyword>
</DOC>